AU2013263786B2 - Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases - Google Patents
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseasesInfo
- Publication number
- AU2013263786B2 AU2013263786B2 AU2013263786A AU2013263786A AU2013263786B2 AU 2013263786 B2 AU2013263786 B2 AU 2013263786B2 AU 2013263786 A AU2013263786 A AU 2013263786A AU 2013263786 A AU2013263786 A AU 2013263786A AU 2013263786 B2 AU2013263786 B2 AU 2013263786B2
- Authority
- AU
- Australia
- Prior art keywords
- diseases
- disorders
- treatment
- cell
- various diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Abstract
The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-Jun amino terminal kinase, JNK inhibitor sequences, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of various diseases, or disorders strongly related to JNK signalling, wherein these diseases or disorders are selected from autoimmune disorders, cardiovascular diseases, cancerous diseases, diabetes, including diabetes type 1 or type 2, inflammatory diseases, hair loss, including Alopecia areata, diseases of the lung, neuronal or neurodegenerative diseases, diseases of the liver, diseases of the spine, diseases of the uterus, viral infectious diseases and depressive disorders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013263786A AU2013263786B2 (en) | 2008-05-30 | 2013-11-28 | Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPCT/EP2008/004341 | 2008-05-30 | ||
| AU2009253346A AU2009253346B2 (en) | 2008-05-30 | 2009-06-02 | Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
| AU2013263786A AU2013263786B2 (en) | 2008-05-30 | 2013-11-28 | Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009253346A Division AU2009253346B2 (en) | 2008-05-30 | 2009-06-02 | Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2013263786A1 AU2013263786A1 (en) | 2013-12-19 |
| AU2013263786B2 true AU2013263786B2 (en) | 2016-07-14 |
Family
ID=49760114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013263786A Ceased AU2013263786B2 (en) | 2008-05-30 | 2013-11-28 | Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2013263786B2 (en) |
-
2013
- 2013-11-28 AU AU2013263786A patent/AU2013263786B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013263786A1 (en) | 2013-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2491942E (en) | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various cardiovascular diseases | |
| WO2007031280A3 (en) | Cell-permeable peptide inhibitors of the jnk signal transduction pathway | |
| WO2014206563A3 (en) | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases | |
| WO2007104529A3 (en) | Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling | |
| MX2010005783A (en) | Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same. | |
| EP3461844A3 (en) | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders | |
| WO2009095489A3 (en) | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling | |
| MX2014006399A (en) | Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome. | |
| MX2009012650A (en) | Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders. | |
| MX2009003090A (en) | Novel genes related to glutaminyl cyclase. | |
| EP2274442A4 (en) | Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same | |
| DK2010563T3 (en) | Synthetic MeCP2 sequence for protein substitution therapy | |
| IL169367A0 (en) | Defensin proteins | |
| WO2015197194A3 (en) | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases | |
| WO2010011994A3 (en) | Polypeptides and uses thereof | |
| WO2006043060A3 (en) | Mam domain containing protein | |
| AU2013263786B2 (en) | Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases | |
| WO2010040736A3 (en) | Amino acid sequences directed against il18 and/or the il-18 receptor and polypeptides comprising the same for the treatment of diseases and/or disorders associated with il-18 mediated signaling | |
| WO2016055160A3 (en) | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases | |
| WO2007068913A3 (en) | SRCR-B Domain Containing Proteins | |
| GB0426960D0 (en) | TGR-3 like protein receptor | |
| WO2005060667A3 (en) | Nucleic acid and amino acid sequences involved in pain | |
| WO2007049062A3 (en) | Vwfa-domain containing proteins | |
| WO2002079431A3 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
| WO2003076577A3 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |